Home › Bayer expands patient assistance program for intrauterine devices
 

Keywords :   


Bayer expands patient assistance program for intrauterine devices

2015-02-23 17:11:52| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals Inc. today announced the expansion of its patient assistance program for intrauterine devices . The ARCH program will provide Skyla 13.5 mg and Mirena 52 mg to low-income women who meet eligibility criteria.

Tags: program assistance devices patient

Category:Chemicals

Latest from this category

All news
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
28.06Jotun Launches CX-Rated Anticorrosive Powder Coating
28.06RPM to Announce Fiscal 2024 4Q, Year-End Results
28.06Evonik Commissions New Plant for AEROSIL Silicas
28.06BCFs Coatings Ambassador Program Trains Its 50th Ambassador
28.06Global Green Building Alliance Launches Guide to Net Zero
27.06Nippon Paint Marines FASTAR Coating Honored by JCIA
27.06Jeremy Sukola Named VP of Prime Resins
Chemicals »
30.06Hurricane Beryl Graphics
30.06Tropical Depression Three Graphics
30.06Tropical Depression Three Forecast Discussion Number 1
30.06Tropical Depression Three Wind Speed Probabilities Number 1
30.06Tropical Depression Three Public Advisory Number 1
30.06Summary for Tropical Depression Three (AT3/AL032024)
30.06Tropical Depression Three Forecast Advisory Number 1
30.06Hurricane Beryl Forecast Discussion Number 9
More »